We are live on
!
Find out more
ADIM
Alpha DNA Investment Management Portfolio holdings
AUM
$8.98M
1-Year Est. Return
26.05%
This Fund
S&P 500
This Quarter
Est. Return
+13.62%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87M
AUM Growth
-$6.82M
(-7.3%)
Cap. Flow
+$46M
Cap. Flow
% of AUM
52.86%
Top 10 Holdings %
Top 10 Hldgs %
19.17%
Holding
838
New
190
Increased
180
Reduced
205
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$49.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$12.1M |
| 3 |
SENT
AdvisorShares Alpha DNA Equity Sentiment ETF
SENT
|
+$1.42M |
| 4 |
Zscaler
ZS
|
+$1.05M |
| 5 |
Nike
NKE
|
+$947K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$1.87M |
| 2 |
Snap
SNAP
|
+$1.28M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$1.16M |
| 4 |
NXP Semiconductors
NXPI
|
+$1.16M |
| 5 |
Tractor Supply
TSCO
|
+$1.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.1% |
| 2 | Consumer Discretionary | 19.26% |
| 3 | Financials | 4.57% |
| 4 | Healthcare | 4.2% |
| 5 | Communication Services | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Denali Therapeutics
DNLI
$3.97B
| $4K | ﹤0.01% |
79
+17
| +27% | +$1.14K |
|
402
Dow Inc
DOW
$21.9B
| $4K | ﹤0.01% |
64
-31
| -33% | -$1.85K |
|
403
Brinker International
EAT
$10.2B
| $4K | ﹤0.01% |
63
| – | – |
|
404
Enbridge
ENB
$112B
| $4K | ﹤0.01% |
134
| – | – |
|
405
Enphase Energy
ENPH
$5.39B
| $4K | ﹤0.01% |
26
| – | – |
|
406
Fate Therapeutics
FATE
$294M
| $4K | ﹤0.01% |
63
+16
| +34% | +$1.53K |
|
407
1-800-Flowers.com
FLWS
$262M
| $4K | ﹤0.01% |
154
| – | – |
|
408
Fiverr
FVRR
$325M
| $4K | ﹤0.01% |
20
+8
| +67% | +$1.96K |
|
409
Halozyme
HALO
$11.4B
| $4K | ﹤0.01% |
+109
| New | +$4.98K |
|
410
iShares Core MSCI EAFE ETF
IEFA
$196B
| $4K | ﹤0.01% |
60
-523
| -90% | -$37.4K |
|
411
Kornit Digital
KRNT
$827M
| $4K | ﹤0.01% |
+43
| New | +$4.25K |
|
412
Keros Therapeutics
KROS
$212M
| $4K | ﹤0.01% |
70
+27
| +63% | +$1.71K |
|
413
LivePerson
LPSN
$35.9M
| $4K | ﹤0.01% |
7
-781
| -99% | -$723K |
|
414
MDU Resources
MDU
$4.27B
| $4K | ﹤0.01% |
355
+89
| +33% | +$970 |
|
|
MODV
415
DELISTED
ModivCare
MODV
| $4K | ﹤0.01% |
+31
| New | +$4.82K |
|
416
Nu Skin
NUS
$237M
| $4K | ﹤0.01% |
93
-12,712
| -99% | -$693K |
|
417
Pacific Biosciences
PACB
$361M
| $4K | ﹤0.01% |
130
+49
| +60% | +$1.72K |
|
418
PENN Entertainment
PENN
$2.53B
| $4K | ﹤0.01% |
45
| – | – |
|
419
Pinnacle West Capital
PNW
$12.2B
| $4K | ﹤0.01% |
53
+1
| +2% | +$77 |
|
420
Qualys
QLYS
$6.77B
| $4K | ﹤0.01% |
42
-1,314
| -97% | -$147K |
|
421
Revvity
RVTY
$13.1B
| $4K | ﹤0.01% |
37
+18
| +95% | +$2.49K |
|
422
SLM Corp
SLM
$5.22B
| $4K | ﹤0.01% |
+257
| New | +$3.9K |
|
423
Tronox
TROX
$961M
| $4K | ﹤0.01% |
223
+50
| +29% | +$873 |
|
|
TSE
424
DELISTED
Trinseo
TSE
| $4K | ﹤0.01% |
73
+6
| +9% | +$366 |
|
425
Tesla
TSLA
$1.34T
| $4K | ﹤0.01% |
+18
| New | +$4.52K |
|
Similar funds
CAWM
AI
PC
CP
AVM
CSD
NP
BPWM
Alpha DNA Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, Alpha DNA Investment Management held 838 positions worth $87M, down 7.3% from $93.9M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Alpha DNA Investment Management deployed $46M of net new capital in Q1 2021, opening 190 new positions and adding to 180 existing holdings. Its largest new stake was AdvisorShares Alpha DNA Equity Sentiment ETF: 54,604 shares worth $1.41M.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $1.87M trimmed.
- Alpha DNA Investment Management's largest Q1 2021 buy was AdvisorShares Alpha DNA Equity Sentiment ETF: 54,604 shares worth $1.41M.
- Alpha DNA Investment Management added most to iShares Russell 2000 ETF in Q1 2021, an estimated $49.7M increase.
- Alpha DNA Investment Management's biggest Q1 2021 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $1.87M.
- Alpha DNA Investment Management fully exited BlackLine in Q1 2021, selling an estimated $475K.
- Alpha DNA Investment Management's ten largest holdings make up 19% of its $87M portfolio in Q1 2021.
- Alpha DNA Investment Management opened 190 new positions and closed 92 in Q1 2021.
- Alpha DNA Investment Management's portfolio value fell 7.3% quarter-over-quarter to $87M.
Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.